ARCHIVES

NCI to Close Clinical Branch at Frederick, Move Patients, Protocols To Bethesda

This article is from The Cancer Letter archive.

Vol. 22 No. 20 | May 17, 1996

Download PDF Visit The Full Archive

Related Articles

HHS Pick For FDA May Be Food Safety Expert.

October 5, 2001

Early ADT Doesn’t Offer Survival Advantage—ASCO

April 27, 2007

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

March 26, 1993

NCAB Approves Bypass Budget f $1.685 Billion for FY ’88, $200 Million More Than Asked For ‘87

May 30, 1986

Draft Report Outlines New Toxicological Test Criteria

November 24, 1995

FDA News: FDA Approves Reagent System for Graft-Versus-Host Disease

January 24, 2014